World News
-
BioNTech pays US$205M for FDA voucher amid competition in oncology market
The FDA awarded the voucher to Scholar Rock after approving Isembyld, its therapy for spinal muscular atrophy, in September.
-
ProBio licenses oncology antibody asset to South Korea’s AbTis for ADC development
Under the agreement, ProBio will receive an upfront payment and may earn additional payments upon the achievement of specified development and commercial milestones.
-
AstraZeneca acquires Omniose to expand bacterial vaccine development capabilities
The acquisition gives the pharmaceutical company access to Omniose’s proprietary bioconjugation platform, which is designed to simplify the development and production of bacterial conjugate vaccines.
-
PharmaLogic expands US radiopharmaceutical manufacturing through Lantheus acquisition
The deal will transfer Lantheus’ CDMO operations and manufacturing facility to PharmaLogic, which focuses exclusively on radiopharmaceutical development and production.
-
WHO reports 10.6M TB cases in 2025 as domestic funding rises 14%
The TB burden remains concentrated in 30 countries, which accounted for 88% of new cases in 2025.
-
Rosti Group acquires Alvi Group to expand medical device manufacturing capabilities
The transaction, whose financial terms were not disclosed, adds nearly 400 employees and manufacturing facilities in China, Norway, Poland and Sweden to Rosti’s operations.
-
GE HealthCare establishes MAGNUS Neuro Alliance to accelerate neurological disease research
The alliance will connect current and prospective users of the company’s SIGNA MAGNUS head-only magnetic resonance imaging (MRI) scanner.
-
WHO launches global movement with 240 organizations to strengthen trust in science
It brings together scientists, policymakers, institutional leaders and other stakeholders to address challenges affecting public confidence in scientific evidence.
-
VintaBio puts US$17M Philadelphia viral vector manufacturing facility up for sale
DSI Assignments has now opened the sale to potential buyers, offering both VintaBio’s intellectual property and its 22,500-square-foot production facility in Philadelphia, Pennsylvania.
-
Onkos Surgical secures FDA clearance to expand NanoCept coating across ELEOS implant system
The latest 510(k) clearance authorises NanoCept application to cemented bowed segmental stems, proximal femurs, tibial baseplates and augments.